用MgZnFe层的双氧化物作为一个双功能平台,用于增强子单元疫苗在瘤免疫治疗中的疗效
Xue Wang1, Lu Liu1, Yingying Chen2
1School and Hospital of Stomatology, Liaoning Provincial Key laboratory of Oral Diseases, China Medical University, Shenyang 110101, China.
International journal of pharmaceutics: X
|September 22, 2025
概括
这项研究引入了一种双功能的MgFeZn-Layered双氧化物 (LMFZ) 疫苗平台,可以提高治疗癌症疫苗的疗效. 该LMFZ平台改善了抗原递送,增强了免疫激活,并与免疫抑制性瘤微环境作斗争,以改善抗瘤反应.
科学领域:
- 生物医学工程 生物医学工程
- 免疫学 免疫学 免疫学
- 材料科学 材料科学 材料科学
背景情况:
- 治疗性癌症疫苗面临的挑战包括抗原输送不良,免疫激活不足以及免疫抑制性瘤微环境.
- 这些局限性阻碍了有效的瘤特异性细胞免疫的发展.
研究的目的:
- 开发一种新的双功能疫苗平台,MgFeZn-Layered双氧化物 (LMFZ),用于增强免疫疗法.
- 研究LMFZ作为抗原输送系统和免疫辅助剂的潜力,以克服当前治疗疫苗的局限性.
主要方法:
- 纳米尺寸的LMFZ粒子被载入了抗原,并在小鼠模型中进行周注射.
- 该研究评估了LMFZ对抗原递送,树突细胞 (DC) 成熟,T细胞增殖和瘤微环境的影响.
- 研究的机制包括内体逃逸,瘤酸度的中和,巨细胞极化和自然杀手细胞活动.
主要成果:
- 带有抗原的LMFZ有效地运送到淋巴结,增强DC捕获和交叉呈现.
- LMFZ促进了DC成熟,导致细胞毒性T淋巴细胞增多和瘤透.
- LMFZ中和了瘤酸度,诱导了M1巨细胞的两极分化,并增强了自然杀手细胞的活动,放大了抗瘤免疫力.
- 载有抗原的LMFZ表现出显著的抗瘤疗效,副作用最小.
结论:
- 该平台显示了作为一种创新策略的潜力,以解决当前治疗癌症疫苗的局限性.
- 作为一个双重功能系统,LMFZ可以改善抗原递送和免疫辅助功能,以增强抗瘤反应.
- 这项研究强调了LMFZ疫苗平台在癌症免疫治疗中的临床转化潜力.
更多相关视频
12:42Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
10.1K
07:33Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
2.2K
相关概念视频
01:27Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
01:30Cancer Vaccines
974
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
974
01:31Hybridoma Technology
17.3K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
17.3K